Original paper
Abstract 3564: MicroRNA-145 gene therapy for pancreatic cancer using exosome as carrier source derived from cancer cells
Abstract
Background-Pancreatic cancer (PanCa) is the third deadliest cancer in United States with a poor survival rate. Despite extensive research efforts, there is no substantial progress in cancer therapeutics due to barrier against intracellular drug delivery. Our group has previously identified that microRNA-145 (miR-145) is downregulated in PanCa, the restoration of which inhibits tumor growth and enhances gemcitabine sensitivity. However, lack of...
Paper Details
Title
Abstract 3564: MicroRNA-145 gene therapy for pancreatic cancer using exosome as carrier source derived from cancer cells
Published Date
Jul 1, 2019
Journal
Volume
79
Issue
13_Supplement
Pages
3564 - 3564
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History